405 related articles for article (PubMed ID: 30989336)
1. [Device-device interaction].
Johnson V; Hamm CW; Schmitt J
Herzschrittmacherther Elektrophysiol; 2019 Jun; 30(2):183-190. PubMed ID: 30989336
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
4. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
[TBL] [Abstract][Full Text] [Related]
6. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
[TBL] [Abstract][Full Text] [Related]
7. Device-device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices.
Tanawuttiwat T; Das MK; Miller JM; Guglin ME
Heart Rhythm; 2023 Jun; 20(6):918-926. PubMed ID: 36863637
[TBL] [Abstract][Full Text] [Related]
8. Safety of the Wearable Cardioverter Defibrillator (WCD) in Patients with Implanted Pacemakers.
Schmitt J; Abaci G; Johnson V; Erkapic D; Gemein C; Chasan R; Weipert K; Hamm CW; Klein HU
Pacing Clin Electrophysiol; 2017 Mar; 40(3):271-277. PubMed ID: 27943296
[TBL] [Abstract][Full Text] [Related]
9. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
10. [Interpretation of paced ECGs by the wearable defibrillator : Pitfalls and solutions].
Zylla MM; Thomas D
Herzschrittmacherther Elektrophysiol; 2021 Dec; 32(4):500-503. PubMed ID: 34713343
[TBL] [Abstract][Full Text] [Related]
11. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
[TBL] [Abstract][Full Text] [Related]
12. Defibrillators: Selecting the Right Device for the Right Patient.
Al-Khatib SM; Friedman P; Ellenbogen KA
Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
[TBL] [Abstract][Full Text] [Related]
13. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers.
Geiger MJ; O'Neill P; Sharma A; Skadsen A; Zimerman L; Greenfield RA; Newby KH; Wharton JM; Kent V; Natale A
Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):624-30. PubMed ID: 9080488
[TBL] [Abstract][Full Text] [Related]
14. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
Kusztal M; Nowak K
J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
Sasaki T; Nakamura K; Naito S
Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
[TBL] [Abstract][Full Text] [Related]
16. Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation.
Manninger M; Odeneg T; Fruhwald F; Brussee H; Scherr D
Wien Klin Wochenschr; 2017 Dec; 129(23-24):910-912. PubMed ID: 29124430
[TBL] [Abstract][Full Text] [Related]
17. Concomitant Use of the Subcutaneous Implantable Cardioverter Defibrillator and a Permanent Pacemaker.
Huang J; Patton KK; Prutkin JM
Pacing Clin Electrophysiol; 2016 Nov; 39(11):1240-1245. PubMed ID: 27734502
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy.
Brambatti M; Mathew R; Strang B; Dean J; Goyal A; Hayward JE; Long L; DeMeis P; Smoke M; Connolly SJ; Morillo CA; Amit G; Capucci A; Healey JS
Heart Rhythm; 2015 Oct; 12(10):2148-54. PubMed ID: 26049049
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
[TBL] [Abstract][Full Text] [Related]
20. Sudden Death in Patients With Cardiac Implantable Electronic Devices.
Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E
JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
